Aclarion Secures U.S. Patent Advancing Scalable, AI-Driven Assessment of Chronic Low Back Pain

Patent covers use of AI in workflows of future products to accelerate company’s ability to scale and enhance already strong gross marginsExpands ...

Aclarion Appoints Daniel Keefe as Commercial Director, Western U.S., to Drive Continued Adoption of Nociscan

Commercial leader with proven track record of driving growth, surgeon adoption, and market expansion with innovative spine and surgical ...

Aclarion Receives Pinnacle Award for AI Innovation

Recognition Follows 2025 HLTH Digital Health Award for Nociscan. Award Winning AI Targets a Large and Costly Chronic Low Back Pain Market . BROOMFIELD, Colo., April 14, 2026 (GLOB ...